Consistent with this mechanism, transgenic overexpression of tRNAGly replenishes the cellular tRNAGly pool and rescues defective protein synthesis, prevents ISR activation, and rescues peripheral neuropathy phenotypes in Drosophila and mouse PN-GlyRS models [12]. The gene discussed is GARS1; the disease is peripheral neuropathy.